INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Showing studies that examined garlic. Clear

6 studies

2019 / Meta-analysis of randomized controlled trials

Garlic supplementation reduced circulating inflammatory markers CRP, IL-6, and TNF in adults.

A meta-analysis of 16 randomized controlled trials evaluated garlic doses between 12 and 3,600 mg daily for 2 to 52 weeks. Garlic administration lowered serum C-reactive protein (WMD -0.61 mg/L, 95% CI -1.12 to -0.11), IL-6 (WMD -0.73 ng/L, 95% CI -1.06 to -0.40), and TNF (WMD -0.26 ng/L, 95% CI -0.41 to -0.12). Conversely, garlic exerted no significant effect on adiponectin or leptin levels.

Darooghegi Mofrad M, Milajerdi A, Koohdani F, et al. J Nutr, 2019. PMID 30949665

2018 / Systematic review

Evidence for superfood effects on metabolic syndrome risk factors remains limited

A systematic review evaluated 113 controlled human intervention trials testing 17 putative superfoods on risk markers for metabolic syndrome. Studied foods included garlic (21 trials), flaxseed (22 trials), cocoa (16 trials), blueberries (8 trials), and strawberries (7 trials). The authors found limited overall evidence for beneficial impacts on waist circumference, BMI, blood pressure, blood glucose, or lipids, citing inconsistent findings across trials and a small number of studies for many evaluated foods.

van den Driessche JJ, Plat J, Mensink RP Food Funct, 2018. PMID 29557436

2014 / Systematic review of randomized controlled trials

Clinical trial evidence is insufficient to confirm garlic prevents or treats colds.

A systematic review identified only one eligible trial evaluating garlic supplementation for the common cold. That study randomized 146 participants to daily garlic or placebo for 12 weeks, finding fewer colds in the garlic arm (24 versus 65, P < 0.001) and fewer sick days (111 versus 366). Days to recovery were comparable (4.63 versus 5.63 days), leaving insufficient evidence to draw firm conclusions.

Lissiman E, Bhasale AL, Cohen M Cochrane Database Syst Rev, 2014. PMID 25386977

2020 / Randomized controlled trial (secondary analysis)

Garlic supplementation was linked to reduced gastric cancer mortality primarily in non-drinkers.

In a secondary analysis of a factorial randomized trial involving 3,365 adults followed for 22.3 years, smoking was associated with increased risk of gastric cancer incidence (OR, 1.72; 95% CI, 1.003-2.93) and mortality (HR, 2.01; 95% CI, 1.01-3.98). Garlic supplementation was associated with reduced gastric cancer mortality exclusively among individuals who never drank alcohol (HR, 0.33; 95% CI, 0.15-0.75; interaction P = .03). No significant interactions occurred between vitamin supplementation and lifestyle behaviors.

Guo Y, Li ZX, Zhang JY, et al. JAMA Netw Open, 2020. PMID 32589229

2018 / Bioavailability study

Allicin bioavailability varies widely across different garlic supplements and foods.

In 13 human participants, allicin bioavailability or bioequivalence was measured across 13 garlic supplements and 9 garlic preparations using breath allyl methyl sulfide after ingestion. Enteric tablets showed 36% to 104% bioavailability, which fell to 22% to 57% with high-protein meals. Non-enteric tablets achieved 80% to 111%, while cooked garlic foods lacking alliinase activity still yielded unexpected bioavailability ranging from 16% to 66%.

Lawson LD, Hunsaker SM Nutrients, 2018. PMID 29937536

2002 / Narrative review

A review examined the placebo effect and outcomes of dietary supplement trials for urologic and non-urologic conditions, including cancer.

This article reviews the role of the placebo effect and randomized controlled trials in evaluating alternative medicine and dietary supplements. It discusses both positive and negative results from randomized trials using supplements such as androstenedione, beta-carotene, CoQ10, garlic, soy, and vitamins C and E. Evaluated conditions include a number of non-urologic and urologic conditions, including cancer.

Moyad MA Urol Clin North Am, 2002. PMID 12109341